CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Vietnam

Publisher Name:
Published Date: 1-Jul-2016
No. of pages: 147

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Vietnam”. It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Vietnam, identifying key trends in the healthcare market and providing insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market, using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts.

In 2015, Vietnam’s population stood at 92 million, an increase from 85 million in 2008 due to the high birth rate and low mortality rate. The country’s pharmaceutical market was estimated to have been worth $3.5 billion in 2015 and is expected to reach $6.6 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 13.8%. The medical device market was estimated at approximately $295m in 2015 and is expected to grow at a CAGR of 11.3% to $505m by 2020.

The positive trends in Vietnam’s healthcare market can primarily be attributed to –

  • Increasing coverage of healthcare insurance
  • Government initiatives to improve healthcare facilities

Scope

The report includes –

  • Overview of the pharmaceutical and medical device markets, including size, segmentation and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, Hau Giang Pharmaceuticals (DHG Pharmaceuticals), Imexpharm, Traphaco and Domesco.
  • An insightful review of the reimbursement and regulatory landscape, covering the healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices.
  • Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

The report will enhance your decision-making capability by allowing you to –

  • Develop business strategies through an understanding of the trends shaping and driving the healthcare market
  • Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical device market segments and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment and strategic partnership
  • Identify, understand and capitalize on the opportunities and challenges in the healthcare market

Table of Contents For This Report

Table of Contents

1 Table of Contents 6

1.1 List of Tables 10

1.2 List of Figures 13

2 Introduction 16

2.1 GlobalData Report Guidance 16

3 Overview of the Pharmaceutical and Medical Device Markets 17

3.1 Pharmaceutical Market 17

3.1.1 Market Overview 17

3.1.2 Pharmaceutical Exports and Imports 19

3.1.3 Supply Channels 20

3.1.4 Market Segments 21

3.1.5 Major Disease Areas 24

3.1.6 Major Companies 27

3.2 Medical Device Market 45

3.3 Market Drivers and Barriers 47

3.3.1 Drivers 47

3.3.2 Barriers 47

4 Market Access 49

4.1 Reimbursement and Payer Landscape 49

4.1.1 Overview of Healthcare System 49

4.1.2 Reimbursement Process 50

4.1.3 Overview of Insurance Providers 51

4.1.4 Patient Share in Healthcare Spending 54

4.1.5 Price Trends in Healthcare Sector 54

4.1.6 Pricing Policies 55

4.2 Regulatory Landscape 56

4.2.1 Overview of Regulatory Agencies 56

4.2.2 Market Authorization Procedure for Pharmaceutical Products 57

4.2.3 New Medical Device Approval Process 62

4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 64

4.2.5 Licensing Process for Pharmaceutical Exports and Imports 65

4.2.6 Intellectual Property Rights 67

4.2.7 Clinical Trial Regulations 71

4.2.8 Pharmaceutical Advertising Regulations 72

4.2.9 Pharmacy Regulations 74

4.2.10 Labeling and Packaging Regulations 75

5 Country Analysis 78

5.1 Political Environment 78

5.1.1 Political Structure 78

5.1.2 Analysis of the Current Political Environment 78

5.1.3 Healthcare Policy Initiatives 79

5.2 Economic Landscape 81

5.3 Economic Indicators 83

5.3.1 Gross Domestic Product 83

5.3.2 Gross National Income 87

5.3.3 Inflation 88

5.3.4 Currency Exchange Rate 91

5.3.5 Foreign Direct Investment 92

5.3.6 Foreign Exchange Reserves 93

5.3.7 Trade Balance 94

5.3.8 General Government Structural Balance 96

5.3.9 General Government Net Debt 97

5.3.10 Major Industries 99

5.4 Demographics 100

5.4.1 Population 100

5.4.2 Education and Literacy 115

5.4.3 Employment 116

5.4.4 Disease Burden 117

5.5 Healthcare Infrastructure 119

5.5.1 Healthcare Facilities 119

5.5.2 Healthcare Parameters 122

5.5.3 Environmental Health 124

5.5.4 Healthcare Personnel 126

5.6 Healthcare Expenditure 129

5.6.1 Overview 129

5.6.2 Major Components of Healthcare Spending 130

5.6.3 Public and Private Sector Share 131

5.6.4 Spending in Healthcare R&D 131

5.7 Trade Associations 132

5.7.1 Vietnam Pharmaceutical Companies Association 132

5.7.2 Vietnam General Association of Medicine and Pharmacy 132

5.7.3 Vietnam Public Health Association 132

5.8 Trade Fairs 133

6 Opportunities and Challenges 134

6.1 Opportunities 134

6.2 Challenges 134

7 Appendix 136

7.1 Abbreviations 136

7.2 Bibliography 138

7.3 Research Methodology 144

7.3.1 Coverage 145

7.3.2 Secondary Research 145

7.3.3 Forecasts 146

7.3.4 Expert Panel 146

7.4 Disclaimer 146

List of Tables

Table 1: Pharmaceutical Market, Vietnam, Revenue ($bn), 2008-2015 18

Table 2: Pharmaceutical Market, Vietnam, Revenue Forecast ($bn), 2016-2020 18

Table 3: Pharmaceutical Market, Vietnam, Exports and Imports ($m), 2008-2015 19

Table 4: Pharmaceutical Market, Vietnam, Generic Market Revenue ($bn), 2008-2015 22

Table 5: OTC Market, Vietnam, Revenue ($m), 2008-2015 23

Table 6: Pharmaceutical Market, Vietnam, Major Disease Areas, Prevalence and Number of Mental Disorder Cases, 2005 26

Table 7: Pharmaceutical Market, Sanofi, Major Products, 2015 28

Table 8: Pharmaceutical Market, Sanofi, Global, Late-Stage Pipeline, 2016 29

Table 9: Pharmaceutical Market, DHG Pharmaceutical, Major Products, 2015 35

Table 10: Pharmaceutical Market, Traphaco, Major Products, 2015 37

Table 11: Pharmaceutical Market, Domesco, Major Products, 2015 43

Table 12: Medical Device Market, Vietnam, Revenue ($m), 2008-2015 46

Table 13: Medical Device Market, Vietnam, Revenue ($m), 2016-2020 46

Table 14: Market Access, Vietnam, Health Insurance Population Coverage (%), 2008-2015 53

Table 15: Market Access, Vietnam, Out-of-Pocket Expenditure (%), 2008-2015 54

Table 16: Market Access, Vietnam, Change in Average Price of Healthcare Services (%), 2008-2015 55

Table 17: Regulatory Landscape, Vietnam, Trademark Filing Fees and Charges, 2015 69

Table 18: Regulatory Landscape, Vietnam, Labeling Guidelines, 2015 76

Table 19: Economic Indicators, Vietnam, GDP per Capita ($), 2008-2015 83

Table 20: Economic Indicators, Vietnam, GDP per Capita Forecast ($), 2016-2020 84

Table 21: Economic Indicators, Vietnam, GDP Annual Growth (%), 2008-2015 85

Table 22: Economic Indicators, Vietnam, GDP Annual Growth (%), 2016-2020 86

Table 23: Economic Indicators, Vietnam, GNI Per Capita ($), 2008-2015 87

Table 24: Economic Indicators, Vietnam, Consumer Price Index, 2008-2015 88

Table 25: Economic Indicators, Vietnam, Consumer Price Index, 2016-2020 89

Table 26: Economic Indicators, Vietnam, Consumer Price Annual Change (%), 2008-2015 90

Table 27: Economic Indicators, Vietnam Currency Exchange Rate ($/VND) 2008-2015 91

Table 28: Economic Indicators, Vietnam, FDI ($bn), 2008-2015 92

Table 29: Economic Indicators, Vietnam, Foreign Exchange Reserves ($bn), 2008-2015 93

Table 30: Economic Indicators, Vietnam, Imports of Goods and Services ($bn), 2008-2015 94

Table 31: Economic Indicators, Vietnam, Exports of Goods and Services ($bn), 2008-2015 95

Table 32: Economic Indicators, Vietnam, Government Structural Balance ($bn), 2008-2015 96

Table 33: Economic Indicators, Vietnam, General Government Net Debt ($bn), 2008-2015 97

Table 34: Economic Indicators, Vietnam, General Government Net Debt Forecast ($bn), 2016-2020 98

Table 35: Economic Indicators, Vietnam, Major Industries, Population Employed (million), 2014 99

Table 36: Demographics, Vietnam, Population (million), 2008-2015 100

Table 37: Demographics, Vietnam, Population (million), 2016-2020 101

Table 38: Demographics, Vietnam, Population, Urban and Rural Population Share (%), 2008-2015 102

Table 39: Demographics, Vietnam, Population, Urban and Rural Population Share Forecast (%), 2016-2020 103

Table 40: Demographics, Vietnam, Population Distribution by Age Group (%), 2008-2015 104

Table 41: Demographics, Vietnam, Population Distribution by Age Group Forecast (%), 2016-2020 105

Table 42: Demographics, Vietnam, Births (per 1,000 population), 2008-2015 106

Table 43: Demographics, Vietnam, Mortality (per 1,000 population), 2008-2015 107

Table 44: Demographics, Vietnam, Major Causes of Mortality, Number of Deaths (%), 2011 108

Table 45: Demographics, Vietnam, Children under Five, Mortality Rate (per 1,000 live births), 2008-2015 109

Table 46: Demographics, Vietnam, Immunization Rate (%), 2008-2013 110

Table 47: Demographics, Vietnam, Major Causes of Male Mortality, Number of Cases (‘000), 2011 111

Table 48: Demographics, Vietnam, Major Causes of Female Mortality (‘000), 2011 112

Table 49: Demographics, Vietnam, Gender Ratio (M/F), 2008-2015 113

Table 50: Demographics, Vietnam, Life Expectancy at Birth (years), 2008-2015 114

Table 51: Demographics, Vietnam, Gross Enrollment by Level of Education (%), 2008-2015 115

Table 52: Demographics, Vietnam, Unemployment Rate (%), 2008-2015 116

Table 53: Demographics, Vietnam, Number of Deaths by Disease (‘000), 2013 117

Table 54: Demographics, Vietnam, Major Diseases, DALYs (‘000), 2012 119

Table 55: Healthcare Infrastructure, Vietnam, Health Establishments, 2008-2015 120

Table 56: Healthcare Infrastructure, Vietnam, Number of Beds by Type of Establishment, 2008-2015 121

Table 57: Healthcare Infrastructure, Vietnam, Hospital Beds (per 1,000 population), 2008-2015 122

Table 58: Healthcare Infrastructure, Vietnam, Doctors (per 1,000 population), 2008-2015 123

Table 59: Healthcare Infrastructure, Vietnam, PM2.5 (µg/m3), 2008-2015 124

Table 60: Healthcare Infrastructure, Vietnam, CO2 Emissions (metric tons per capita), 2008-2015 125

Table 61: Healthcare Infrastructure, Vietnam, Nurses (per 1,000 population), 2008-2015 126

Table 62: Healthcare Infrastructure, Vietnam, Midwives (per 1,000 population), 2008-2015 127

Table 63: Healthcare Infrastructure, Vietnam, Pharmacists (per 1,000 population), 2008-2015 128

Table 64: Healthcare Expenditure, Vietnam, Healthcare Expenditure (% of GDP), 2008-2015 129

Table 65: Healthcare Expenditure, Vietnam, Public Healthcare Expenditure, Share of Major Components (%), 2013 130

Table 66: Healthcare Expenditure, Vietnam, Healthcare Expenditure, Public-Private Share (%), 2008-2015 131

Table 67: Healthcare Expenditure, Vietnam, Major Healthcare Trade Fairs, 2016 133

List of Figures

Figure 1: Pharmaceutical Market, Vietnam, Revenue ($bn), 2008-2015 17

Figure 2: Pharmaceutical Market, Vietnam, Revenue Forecast ($bn), 2016-2020 18

Figure 3: Pharmaceutical Market, Vietnam, Exports and Imports ($m), 2008-2015 19

Figure 4: Pharmaceutical Market, Vietnam, Supply Chain, 2015 20

Figure 5: Pharmaceutical Market, Vietnam, Distribution channels, 2015 21

Figure 6: Pharmaceutical Market, Vietnam, Generic Market Revenue ($bn), 2008-2015 22

Figure 7: Pharmaceutical Market, Vietnam, OTC Market Revenue ($bn), 2008-2015 23

Figure 8: Medical Device Market, Vietnam, Revenue ($m), 2008-2015 45

Figure 9: Medical Device Market, Vietnam, Revenue ($m), 2016-2020 46

Figure 10: Healthcare Market, Vietnam, Drivers and Barriers, 2016 48

Figure 11: Market Access, Vietnam, Overview of Healthcare System 50

Figure 12: Market Access, Vietnam, Overview of Healthcare System 52

Figure 13: Market Access, Vietnam, Health Insurance Population Coverage (%), 2008-2015 53

Figure 14: Market Access, Vietnam, Out-of-Pocket Expenditure (%), 2008-2015 54

Figure 15: Market Access, Vietnam, Change in Average Price of Healthcare Services (%), 2008-2015 55

Figure 16: Market Access, Vietnam, Marketing Authorization Procedure, 2015 60

Figure 17: Regulatory Landscape, Vietnam, Generic Drug Approval Process, 2015 62

Figure 18: Market Access, Vietnam, Patent Approval Process, 2014 70

Figure 19: Economic Indicators, Vietnam, GDP per Capita ($), 2008-2015 83

Figure 20: Economic Indicators, Vietnam, GDP per Capita ($), 2016-2020 84

Figure 21: Economic Indicators, Vietnam, GDP Annual Growth (%), 2008-2015 85

Figure 22: Economic Indicators, Vietnam, GDP Annual Growth (%), 2016-2020 86

Figure 23: Economic Indicators, Vietnam, GNI Per Capita ($), 2008-2015 87

Figure 24: Economic Indicators, Vietnam, Consumer Price Index, 2008-2015 88

Figure 25: Economic Indicators, Vietnam, Consumer Price Index, 2016-2020 89

Figure 26: Economic Indicators, Vietnam, Consumer Price Annual Change (%), 2008-2015 90

Figure 27: Economic Indicators, Vietnam, Currency Exchange Rate ($/VND) 2008-2015 91

Figure 28: Economic Indicators, Vietnam, FDI ($bn), 2008-2015 92

Figure 29: Economic Indicators, Vietnam, Foreign Exchange Reserves ($bn), 2008-2015 93

Figure 30: Economic Indicators, Vietnam, Imports of Goods and Services ($bn), 2008-2015 94

Figure 31: Economic Indicators, Vietnam, Exports of Goods and Services ($bn), 2008-2015 95

Figure 32: Economic Indicators, Vietnam, Government Structural Balance ($bn), 2008-2015 96

Figure 33: Economic Indicators, Vietnam, General Government Net Debt ($bn), 2008-2015 97

Figure 34: Economic Indicators, Vietnam, General Government Net Debt ($bn), 2016-2020 98

Figure 35: Economic Indicators, Vietnam, Major Industries, Population Employed (million), 2014 99

Figure 36: Demographics, Vietnam, Population (million), 2008-2015 100

Figure 37: Demographics, Vietnam, Population (million), 2016-2020 101

Figure 38: Demographics, Vietnam, Population, Urban and Rural Population Share (%), 2008-2015 102

Figure 39: Demographics, Vietnam, Population, Urban and Rural Population Share (%), 2016-2020 103

Figure 40: Demographics, Vietnam, Population Distribution by Age Group (%), 2008-2015 104

Figure 41: Demographics, Vietnam, Population Distribution by Age Group (%), 2016-2020 105

Figure 42: Demographics, Vietnam, Births (per 1,000 population), 2008-2015 106

Figure 43: Demographics, Vietnam, Mortality (per 1,000 population), 2008-2015 107

Figure 44: Demographics, Vietnam, Major Causes of Mortality, Number of Deaths (%), 2011 108

Figure 45: Demographics, Vietnam, Children under Five, Mortality Rate (per 1,000 live births), 2008-2015 109

Figure 46: Demographics, Vietnam, Immunization Rate (%), 2008-2015 110

Figure 47: Demographics, Vietnam, Major Causes of Male Mortality, Number of Cases (‘000), 2011 111

Figure 48: Demographics, Vietnam, Major Causes of Female Mortality, Number of Cases (‘000), 2011 112

Figure 49: Demographics, Vietnam, Gender Ratio (M/F), 2008-2015 113

Figure 50: Demographics, Vietnam, Life Expectancy at Birth (years), 2008-2015 114

Figure 51: Demographics, Vietnam, Gross Enrollment by Level of Education (%), 2008-2015 115

Figure 52: Demographics, Vietnam, Unemployment Rate (%), 2008-2015 116

Figure 53: Demographics, Vietnam, Number of Cases by Disease (‘000), 2012 117

Figure 54: Demographics, Vietnam, Major Diseases, DALYs (‘000), 2012 118

Figure 55: Healthcare Infrastructure, Vietnam, Health Establishments, 2008-2015 120

Figure 56: Healthcare Infrastructure, Vietnam, Number of Beds by Type of Establishment, 2008-2015 121

Figure 57: Healthcare Infrastructure, Vietnam, Hospital Beds (per 1,000 population), 2008-2015 122

Figure 58: Healthcare Infrastructure, Vietnam, Doctors (per 1,000 population), 2008-2015 123

Figure 59: Healthcare Infrastructure, Vietnam, PM2.5 (µg/m3), 2008-2015 124

Figure 60: Healthcare Infrastructure, Vietnam, CO2 Emissions (metric tons per capita), 2008-2015 125

Figure 61: Healthcare Infrastructure, Vietnam, Nurses (per 1,000 population), 2008-2015 126

Figure 62: Healthcare Infrastructure, Vietnam, Midwives (per 1,000 population), 2008-2015 127

Figure 63: Healthcare Infrastructure, Vietnam, Pharmacists (per 1,000 population), 2008-2015 128

Figure 64: Healthcare Expenditure, Vietnam, Healthcare Expenditure (% of GDP), 2008-2015 129

Figure 65: Healthcare Expenditure, Vietnam, Public Healthcare Expenditure, Share of Major Components (%), 2013 130

Figure 66: Healthcare Expenditure, Vietnam, Public-Private Share of Healthcare Expenditure (%), 2008-2015 131

Figure 67: Healthcare Market, Vietnam, Opportunities and Challenges, 2016 135

Get Updates

Share This Post

Latest Reports from Life Sciences category

© 2016 Market optimizer. All rights reserved.